Skip to content
← Back to this collection

PUBLICATIONS · 28968163

MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Nov 10
First author
Goetz MP

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Goetz MP
      type
      Author
    2. name
      Toi M
      type
      Author
    3. name
      Campone M
      type
      Author
    4. name
      Sohn J
      type
      Author
    5. name
      Paluch-Shimon S
      type
      Author
    6. name
      Huober J
      type
      Author
    7. name
      Park IH
      type
      Author
    8. name
      Trédan O
      type
      Author
    9. name
      Chen SC
      type
      Author
    10. name
      Manso L
      type
      Author
    11. name
      Freedman OC
      type
      Author
    12. name
      Garnica Jaliffe G
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Goetz MP
      type
      Author
    2. name
      Toi M
      type
      Author
    3. name
      Campone M
      type
      Author
    4. name
      Sohn J
      type
      Author
    5. name
      Paluch-Shimon S
      type
      Author
    6. name
      Huober J
      type
      Author
    7. name
      Park IH
      type
      Author
    8. name
      Trédan O
      type
      Author
    9. name
      Chen SC
      type
      Author
    10. name
      Manso L
      type
      Author
    11. name
      Freedman OC
      type
      Author
    12. name
      Garnica Jaliffe G
      type
      Author
    bibliography ids
    1. nci-bib-167a20f8240ccc5ba0e04a8b
    book metadata
    content sha256
    04c82924b7b296933169c4435820456a0b9423bc12a5c7382b0c4fe8d88d647e
    document type
    citation
    dois
    1. 10.1200/JCO.2017.75.6155
    electronic publication date
    display
    2017 Oct 2
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28968163
    immutable id
    pubmed:28968163@04c82924b7b296933169c4435820456a0b9423bc12a5c7382b0c4fe8d88d647e
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    32
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3638-3646
    volume
    35
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28968163
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      a271c3c8e0ab4559b15a43579b4719d7c5f07ba4b9e90edef6e7a2387488a320
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2017 Nov 10
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28968163/
      title
      MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.

      Preserved source evidence · Not medical advice